Research study Program year 2025 Source: CMS Open Payments

A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistent

Research payments

$869,721

24 payments

Through program year 2025, $869,721 in research payments was reported against A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistent, across 24 payments, paid by Merck Sharp & Dohme Corporation.

Paid by: Merck Sharp & Dohme Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$869,721	24

Breakdown

Who paid Research payments · program year 2025

Merck Sharp & Dohme Corporation $869,721 24 payments

Who received the money Research payments · program year 2025

Health Research of Hampton Roads, Inc. Organisation paid for research $195,443 1 payment
Moffitt Cancer Center Teaching hospital · FL $136,166 1 payment
Valley Clinical Trials Inc. Organisation paid for research $79,338 1 payment
Crossroads Clinical Research LLC Organisation paid for research $56,783 1 payment
Cotton-O'Neil Clinical Research Center Organisation paid for research $44,867 1 payment
Acevedo Clinical Research Associates Organisation paid for research $42,035 1 payment
DM Clinical Research - Bellaire Organisation paid for research $40,449 1 payment
Certified Research Associates Organisation paid for research $37,290 1 payment
Rochester Clinical Research, Inc. Organisation paid for research $25,355 1 payment
J Lewis Research Inc,Foothill Family Clinic South Organisation paid for research $23,202 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistent”, Who Paid My Doc, citing CMS Open Payments, program year 2025. https://www.whopaidmydoc.com/research-studies/a-phase-3-international-multi-center-randomized-double-blind-placebo-controlled-clinical-trial-to-study-the-efficacy-immunogenicity-and-safety-of-the-9vhpv-vaccine-a-multivalent-l1-virus-like-particle-vaccine-in-the-prevention-of-oral-persistent-60445397

Figures here may be reproduced with attribution and a link — see for journalists and researchers.